LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Your last searches

  1. AU="Bini, Valentina"
  2. AU="İzet Korkmaz"
  3. AU="Hosseini, Davood"

Search results

Result 1 - 10 of total 18

Search options

  1. Article: Combined Antagonism of 5-HT

    Frau, Roberto / Pardu, Alessandra / Godar, Sean / Bini, Valentina / Bortolato, Marco

    Pharmaceuticals (Basel, Switzerland)

    2022  Volume 15, Issue 2

    Abstract: The enzyme monoamine oxidase A (MAOA) catalyzes the degradation of several neurotransmitters, including serotonin. A large body of evidence has shown that genetic MAOA deficiency predisposes humans and mice to aggression and antisocial behavior. We ... ...

    Abstract The enzyme monoamine oxidase A (MAOA) catalyzes the degradation of several neurotransmitters, including serotonin. A large body of evidence has shown that genetic MAOA deficiency predisposes humans and mice to aggression and antisocial behavior. We previously documented that the aggression of male MAOA-deficient mice is contributed by serotonin 5-HT
    Language English
    Publishing date 2022-02-10
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2193542-7
    ISSN 1424-8247
    ISSN 1424-8247
    DOI 10.3390/ph15020213
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Role of maintenance treatment on long-term efficacy of bilateral iTBS of the prefrontal cortex in treatment-seeking cocaine addicts: A retrospective analysis.

    Sanna, Angela / Bini, Valentina / Badas, Paola / Corona, Giorgio / Sanna, Gabriele / Marcasciano, Lara / De Vivo, Maria Chiara / Diana, Marco

    Frontiers in psychiatry

    2022  Volume 13, Page(s) 1013569

    Abstract: CUD, like other addictions, is a chronic disease characterized by a high rate of relapse and drop-out (DO) from medical and behavioral treatment programs, which is positively correlated with relapse. Repetitive transcranial Magnetic Stimulation (rTMS) ... ...

    Abstract CUD, like other addictions, is a chronic disease characterized by a high rate of relapse and drop-out (DO) from medical and behavioral treatment programs, which is positively correlated with relapse. Repetitive transcranial Magnetic Stimulation (rTMS) protocols have shown therapeutic potential in addiction in the short term, but only a few studies have explored their long-term efficacy, so far. This study explores the long-term outcome of bilateral intermittent theta-burst stimulation (iTBS) of the prefrontal cortex (PFC) in cocaine use disorder (CUD) and the possible influence of maintenance treatment in improving abstinence and decreasing DO rates. Eighty-nine treatment-seeking CUD patients were exposed to 20 sessions of iTBS. At the end of the treatment 61 (81%) abstinent patients underwent a 12 months follow-up. Among these, 27 patients chose to follow a maintenance treatment (M), whereas 34 patients chose not to adhere to a maintenance treatment (NM). Overall, among patients reaching the 12 months follow-up endpoint, 69.7% were still abstinent and 30.3% relapsed. In NM-patients the DO rate was significantly higher than in M-ones (58.82 vs. 29.63%). The present observations show the long-term therapeutic effect of bilateral PFC iTBS to decrease cocaine consumption. Moreover, they underline the importance to perform a maintenance protocol to consolidate abstinence and decrease DO rates over time.
    Language English
    Publishing date 2022-11-08
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2564218-2
    ISSN 1664-0640
    ISSN 1664-0640
    DOI 10.3389/fpsyt.2022.1013569
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Targeting neurosteroid synthesis as a therapy for schizophrenia-related alterations induced by early psychosocial stress.

    Frau, Roberto / Abbiati, Federico / Bini, Valentina / Casti, Alberto / Caruso, Donatella / Devoto, Paola / Bortolato, Marco

    Schizophrenia research

    2015  Volume 168, Issue 3, Page(s) 640–648

    Abstract: Background: Cogent evidence has shown that schizophrenia vulnerability is enhanced by psychosocial stress in adolescence, yet the underpinnings of this phenomenon remain elusive. One of the animal models that best capture the relationship between ... ...

    Abstract Background: Cogent evidence has shown that schizophrenia vulnerability is enhanced by psychosocial stress in adolescence, yet the underpinnings of this phenomenon remain elusive. One of the animal models that best capture the relationship between juvenile stress and schizophrenia is isolation rearing (IR). This manipulation, which consists in subjecting rats to social isolation from weaning through adulthood, results in neurobehavioral alterations akin to those observed in schizophrenia patients. In particular, IR-subjected rats display a marked reduction of the prepulse inhibition (PPI) of the startle reflex, which are posited to reflect imbalances in dopamine neurotransmission in the nucleus accumbens (NAcc). We recently documented that the key neurosteroidogenic enzyme 5α-reductase (5αR) plays an important role in the dopaminergic regulation of PPI; given that IR leads to a marked down-regulation of this enzyme in the NAcc, the present study was designed to further elucidate the functional role of 5αR in the regulation of PPI of IR-subjected rats.
    Methods: We studied the impact of the prototypical 5αR inhibitor finasteride (FIN) on the PPI deficits and NAcc steroid profile of IR-subjected male rats, in comparison with socially reared (SR) controls.
    Results: FIN (25-100 mg/kg, i.p.) dose-dependently countered IR-induced PPI reduction, without affecting gating integrity in SR rats. The NAcc and striatum of IR-subjected rats displayed several changes in neuroactive steroid profile, including a reduction in pregnenolone in both SR and IR-subjected groups, as well as a decrease in allopregnanolone content in the latter group; both effects were significantly opposed by FIN.
    Conclusions: These results show that 5αR inhibition counters the PPI deficits induced by IR, possibly through limbic changes in pregnenolone and/or allopregnanolone concentrations.
    MeSH term(s) 3-Oxo-5-alpha-Steroid 4-Dehydrogenase/metabolism ; 5-alpha Reductase Inhibitors/pharmacology ; Animals ; Antipsychotic Agents/pharmacology ; Corpus Striatum/drug effects ; Corpus Striatum/metabolism ; Disease Models, Animal ; Dose-Response Relationship, Drug ; Finasteride/pharmacology ; Haloperidol/pharmacology ; Injections, Intraperitoneal ; Male ; Nucleus Accumbens/drug effects ; Nucleus Accumbens/metabolism ; Pregnenolone/metabolism ; Prepulse Inhibition/drug effects ; Prepulse Inhibition/physiology ; Random Allocation ; Rats, Sprague-Dawley ; Reflex, Startle/drug effects ; Reflex, Startle/physiology ; Schizophrenia/drug therapy ; Schizophrenia/metabolism ; Social Isolation ; Stress, Psychological/drug therapy ; Stress, Psychological/metabolism
    Chemical Substances 5-alpha Reductase Inhibitors ; Antipsychotic Agents ; Finasteride (57GNO57U7G) ; Pregnenolone (73R90F7MQ8) ; 3-Oxo-5-alpha-Steroid 4-Dehydrogenase (EC 1.3.99.5) ; Haloperidol (J6292F8L3D)
    Language English
    Publishing date 2015-11
    Publishing country Netherlands
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 639422-x
    ISSN 1573-2509 ; 0920-9964
    ISSN (online) 1573-2509
    ISSN 0920-9964
    DOI 10.1016/j.schres.2015.04.044
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: Vulnerability Factors for the Psychiatric and Behavioral Effects of Cannabis.

    Bortolato, Marco / Bini, Valentina / Tambaro, Simone

    Pharmaceuticals (Basel, Switzerland)

    2010  Volume 3, Issue 9, Page(s) 2799–2820

    Abstract: Cogent evidence shows that cannabis plays a variable role on behavioral regulation and the pathophysiology of most psychiatric conditions. Accordingly, cannabis has been alternatively shown to exacerbate or ameliorate mental symptoms, depending on its ... ...

    Abstract Cogent evidence shows that cannabis plays a variable role on behavioral regulation and the pathophysiology of most psychiatric conditions. Accordingly, cannabis has been alternatively shown to exacerbate or ameliorate mental symptoms, depending on its composition and route of consumption, as well as specific individual and contextual characteristics. The vulnerability to the psychological effects of cannabis is influenced by a complex constellation of genetic and environmental factors. In the present article, we will review the current evidence on the pharmacological, individual and situational factors that have been documented to affect the behavioral and psychiatric effects of cannabinoids.
    Language English
    Publishing date 2010-08-26
    Publishing country Switzerland
    Document type Review ; Journal Article
    ZDB-ID 2193542-7
    ISSN 1424-8247
    ISSN 1424-8247
    DOI 10.3390/ph3092799
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: The dopamine beta-hydroxylase inhibitor nepicastat increases dopamine release and potentiates psychostimulant-induced dopamine release in the prefrontal cortex.

    Devoto, Paola / Flore, Giovanna / Saba, Pierluigi / Bini, Valentina / Gessa, Gian Luigi

    Addiction biology

    2014  Volume 19, Issue 4, Page(s) 612–622

    Abstract: The dopamine-beta-hydroxylase inhibitor nepicastat has been shown to reproduce disulfiram ability to suppress the reinstatement of cocaine seeking after extinction in rats. To clarify its mechanism of action, we examined the effect of nepicastat, given ... ...

    Abstract The dopamine-beta-hydroxylase inhibitor nepicastat has been shown to reproduce disulfiram ability to suppress the reinstatement of cocaine seeking after extinction in rats. To clarify its mechanism of action, we examined the effect of nepicastat, given alone or in association with cocaine or amphetamine, on catecholamine release in the medial prefrontal cortex and the nucleus accumbens, two key regions involved in the reinforcing and motivational effects of cocaine and in the reinstatement of cocaine seeking. Nepicastat effect on catecholamines was evaluated by microdialysis in freely moving rats. Nepicastat reduced noradrenaline release both in the medial prefrontal cortex and in the nucleus accumbens, and increased dopamine release in the medial prefrontal cortex but not in the nucleus accumbens. Moreover, nepicastat markedly potentiated cocaine- and amphetamine-induced extracellular dopamine accumulation in the medial prefrontal cortex but not in the nucleus accumbens. Extracellular dopamine accumulation produced by nepicastat alone or by its combination with cocaine or amphetamine was suppressed by the α2 -adrenoceptor agonist clonidine. It is suggested that nepicastat, by suppressing noradrenaline synthesis and release, eliminated the α2 -adrenoceptor mediated inhibitory mechanism that constrains dopamine release and cocaine- and amphetamine-induced dopamine release from noradrenaline or dopamine terminals in the medial prefrontal cortex.
    MeSH term(s) Amphetamine/administration & dosage ; Animals ; Cocaine/administration & dosage ; Dopamine/metabolism ; Dopamine Uptake Inhibitors/administration & dosage ; Drug Synergism ; Imidazoles/pharmacology ; Male ; Microdialysis/methods ; Norepinephrine/metabolism ; Nucleus Accumbens/drug effects ; Prefrontal Cortex/drug effects ; Prefrontal Cortex/metabolism ; Rats ; Rats, Sprague-Dawley ; Thiones/pharmacology
    Chemical Substances Dopamine Uptake Inhibitors ; Imidazoles ; Thiones ; Amphetamine (CK833KGX7E) ; Cocaine (I5Y540LHVR) ; nepicastat (VPG12K4540) ; Dopamine (VTD58H1Z2X) ; Norepinephrine (X4W3ENH1CV)
    Language English
    Publishing date 2014-07
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1324314-7
    ISSN 1369-1600 ; 1355-6215
    ISSN (online) 1369-1600
    ISSN 1355-6215
    DOI 10.1111/adb.12026
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Inhibition of 17α-hydroxylase/C17,20 lyase reduces gating deficits consequent to dopaminergic activation.

    Frau, Roberto / Bini, Valentina / Pes, Romina / Pillolla, Giuliano / Saba, Pierluigi / Devoto, Paola / Bortolato, Marco

    Psychoneuroendocrinology

    2013  Volume 39, Page(s) 204–213

    Abstract: Cogent evidence points to the involvement of neurosteroids in the regulation of dopamine (DA) neurotransmission and signaling, yet the neurobiological bases of this link remain poorly understood. We previously showed that inhibition of 5α-reductase (5αR), ...

    Abstract Cogent evidence points to the involvement of neurosteroids in the regulation of dopamine (DA) neurotransmission and signaling, yet the neurobiological bases of this link remain poorly understood. We previously showed that inhibition of 5α-reductase (5αR), a key neurosteroidogenic enzyme, attenuates the sensorimotor gating deficits induced by DA receptor activation, as measured by the prepulse inhibition (PPI) of the acoustic startle reflex. To extend these findings, the present study was aimed at the assessment of the role of other key neurosteroidogenic enzymes in PPI, such as 17α-hydroxylase/C17,20 lyase (CYP17A1), 3α- and 3β-hydroxysteroid dehydrogenase (HSD), in Sprague-Dawley rats. The PPI deficits induced by the DAergic non-selective agonist apomorphine (APO, 0.25mg/kg, SC) were dose-dependently attenuated by the selective CYP17A1 inhibitor abiraterone (ABI, 10-50mg/kg, IP) in a fashion akin to that of the 5αR inhibitor finasteride (FIN, 100mg/kg, IP). These systemic effects were reproduced by intracerebroventricular injection of ABI (1 μg/1 μl), suggesting the involvement of brain CYP17A1 in PPI regulation. Conversely, the PPI disruption induced by APO was not significantly affected by the 3α- and 3β-HSD inhibitors indomethacin and trilostane. Given that CYP17A1 catalyzes androgen synthesis, we also tested the impact on PPI of the androgen receptor (AR) antagonist flutamide (10mg/kg, IP). However, this agent failed to reverse APO-induced PPI deficits; furthermore, AR endogenous ligands testosterone and dihydrotestosterone failed to disrupt PPI. Collectively, these data highlight CYP17A1 as a novel target for antipsychotic-like action, and suggest that the DAergic regulation of PPI is modulated by androgenic neurosteroids, through AR-unrelated mechanisms.
    MeSH term(s) 5-alpha Reductase Inhibitors/pharmacology ; Androstenes ; Androstenols/pharmacology ; Animals ; Apomorphine/pharmacology ; Dopamine Agonists/pharmacology ; Finasteride/pharmacology ; Male ; Rats ; Rats, Sprague-Dawley ; Reflex, Startle/drug effects ; Sensory Gating/drug effects ; Steroid 17-alpha-Hydroxylase/antagonists & inhibitors
    Chemical Substances 5-alpha Reductase Inhibitors ; Androstenes ; Androstenols ; Dopamine Agonists ; Finasteride (57GNO57U7G) ; Steroid 17-alpha-Hydroxylase (EC 1.14.14.19) ; abiraterone (G819A456D0) ; Apomorphine (N21FAR7B4S)
    Language English
    Publishing date 2013-09-21
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Extramural
    ZDB-ID 197636-9
    ISSN 1873-3360 ; 0306-4530
    ISSN (online) 1873-3360
    ISSN 0306-4530
    DOI 10.1016/j.psyneuen.2013.09.014
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: The neurosteroidogenic enzyme 5α-reductase modulates the role of D1 dopamine receptors in rat sensorimotor gating.

    Frau, Roberto / Mosher, Laura J / Bini, Valentina / Pillolla, Giuliano / Pes, Romina / Saba, Pierluigi / Fanni, Silvia / Devoto, Paola / Bortolato, Marco

    Psychoneuroendocrinology

    2015  Volume 63, Page(s) 59–67

    Abstract: Neurosteroids exert diverse modulatory actions on dopamine neurotransmission and signaling. We previously documented that the enzyme 5α-reductase, which catalyzes the main rate-limiting step in neurosteroid synthesis, is required for the behavioral ... ...

    Abstract Neurosteroids exert diverse modulatory actions on dopamine neurotransmission and signaling. We previously documented that the enzyme 5α-reductase, which catalyzes the main rate-limiting step in neurosteroid synthesis, is required for the behavioral responses of Sprague-Dawley rats to non-selective dopaminergic agonists, such as the D1-D2 receptor agonist apomorphine. Specifically, systemic and intra-accumbal administrations of the 5α-reductase inhibitor finasteride countered apomorphine-induced deficits of sensorimotor gating, as measured by the prepulse inhibition (PPI) of the startle reflex; the classes of dopamine receptors involved in these effects, however, remain unknown. Prior rodent studies have revealed that the contributions of dopamine receptors to PPI regulation vary depending on the genetic background; thus, we analyzed the effect of finasteride on the PPI deficits induced by selective dopamine receptor agonists in Long-Evans (a strain exhibiting PPI deficits in response to both D1 and D2 receptor agonists) and Sprague-Dawley rats (which display PPI reductions following treatment with D2, and D3, but not D1 receptor agonists). In Long-Evans rats, finasteride opposed the PPI deficits induced by activation of D1, but not D2 receptors; conversely, in Sprague-Dawley rats, finasteride prevented the reductions in %PPI and accumbal dopamine extracellular levels caused by selective stimulation of D3, but not D2 receptors; however, the effects on %PPI were not confirmed by analyses on absolute PPI values. Our findings suggest that 5α-reductase modulates the effects of D1, but not D2 receptor agonists on sensorimotor gating. These data may help elucidate the role of neurosteroids in neuropsychiatric disorders featuring PPI deficits, including schizophrenia and Tourette syndrome.
    MeSH term(s) 3-Oxo-5-alpha-Steroid 4-Dehydrogenase/metabolism ; 5-alpha Reductase Inhibitors/pharmacology ; Animals ; Dopamine Agonists/pharmacology ; Finasteride/pharmacology ; Male ; Microdialysis ; Nucleus Accumbens/drug effects ; Nucleus Accumbens/metabolism ; Prepulse Inhibition/drug effects ; Prepulse Inhibition/physiology ; Rats ; Rats, Long-Evans ; Rats, Sprague-Dawley ; Receptors, Dopamine D1/drug effects ; Receptors, Dopamine D1/metabolism ; Receptors, Dopamine D2/drug effects ; Receptors, Dopamine D2/metabolism ; Receptors, Dopamine D3/drug effects ; Receptors, Dopamine D3/metabolism ; Reflex, Startle/drug effects ; Reflex, Startle/physiology ; Sensory Gating/drug effects ; Sensory Gating/physiology
    Chemical Substances 5-alpha Reductase Inhibitors ; Dopamine Agonists ; Receptors, Dopamine D1 ; Receptors, Dopamine D2 ; Receptors, Dopamine D3 ; Finasteride (57GNO57U7G) ; 3-Oxo-5-alpha-Steroid 4-Dehydrogenase (EC 1.3.99.5)
    Language English
    Publishing date 2015-09-24
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 197636-9
    ISSN 1873-3360 ; 0306-4530
    ISSN (online) 1873-3360
    ISSN 0306-4530
    DOI 10.1016/j.psyneuen.2015.09.014
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Finasteride attenuates pathological gambling in patients with Parkinson disease.

    Bortolato, Marco / Cannas, Antonino / Solla, Paolo / Bini, Valentina / Puligheddu, Monica / Marrosu, Francesco

    Journal of clinical psychopharmacology

    2012  Volume 32, Issue 3, Page(s) 424–425

    MeSH term(s) 5-alpha Reductase Inhibitors/therapeutic use ; Aged ; Antiparkinson Agents/adverse effects ; Antiparkinson Agents/therapeutic use ; Benzothiazoles/adverse effects ; Benzothiazoles/therapeutic use ; Carbidopa/therapeutic use ; Catechols/therapeutic use ; Drug Combinations ; Drug Monitoring ; Drug Therapy, Combination/adverse effects ; Ergolines/adverse effects ; Ergolines/therapeutic use ; Finasteride/therapeutic use ; Gambling/chemically induced ; Gambling/prevention & control ; Humans ; Levodopa/therapeutic use ; Male ; Middle Aged ; Nitriles/therapeutic use ; Parkinson Disease/drug therapy ; Treatment Outcome ; Video Games
    Chemical Substances 5-alpha Reductase Inhibitors ; Antiparkinson Agents ; Benzothiazoles ; Catechols ; Drug Combinations ; Ergolines ; Nitriles ; carbidopa, levodopa drug combination ; Levodopa (46627O600J) ; entacapone (4975G9NM6T) ; Finasteride (57GNO57U7G) ; pramipexole (83619PEU5T) ; cabergoline (LL60K9J05T) ; Carbidopa (MNX7R8C5VO)
    Language English
    Publishing date 2012-06
    Publishing country United States
    Document type Case Reports ; Letter
    ZDB-ID 604631-9
    ISSN 1533-712X ; 0271-0749
    ISSN (online) 1533-712X
    ISSN 0271-0749
    DOI 10.1097/JCP.0b013e3182549c2a
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Inhibition of 5α-reductase attenuates behavioral effects of D1-, but not D2-like receptor agonists in C57BL/6 mice.

    Frau, Roberto / Pillolla, Giuliano / Bini, Valentina / Tambaro, Simone / Devoto, Paola / Bortolato, Marco

    Psychoneuroendocrinology

    2012  Volume 38, Issue 4, Page(s) 542–551

    Abstract: Converging lines of evidence point to the involvement of neurosteroids in the regulation of dopamine (DA) neurotransmission and signaling, yet the neurobiological bases of this link remain poorly understood. We previously showed that inhibition of ... ...

    Abstract Converging lines of evidence point to the involvement of neurosteroids in the regulation of dopamine (DA) neurotransmission and signaling, yet the neurobiological bases of this link remain poorly understood. We previously showed that inhibition of steroid 5α-reductase (5αR), the key rate-limiting enzyme in neurosteroidogenesis, attenuates the behavioral effects of non-selective DA receptor agonists in rats, including stereotyped responses and sensorimotor gating deficits, as measured by the prepulse inhibition (PPI) of the acoustic startle reflex. Since previous findings suggested that the role of DA D(1)- and D(2)-like receptor families in behavioral regulation may exhibit broad interspecies and interstrain variations, we assessed the impact of 5αR blockade on the behavioral effects of DAergic agonists in C57BL/6 mice. The prototypical 5αR inhibitor finasteride (FIN; 25-50 mg/kg, intraperitoneally, IP) dose-dependently countered the PPI deficits and the enhancement of rearing responses induced by the full D(1)-like receptor agonist SKF-82958 (0.3 mg/kg, IP); however, FIN did not significantly affect the hyperlocomotive and startle-attenuating effects of SKF-82958. Whereas the D(2)-like receptor agonist quinpirole (QUIN; 0.5 mg/kg, IP) did not induce significant changes in PPI, the combination of this agent and FIN surprisingly produced marked gating and startle deficits. In contrast with previous data on rats, FIN did not affect the reductions of startle reflex and PPI produced by the non-selective DAergic agonist apomorphine (APO; 0.5 mg/kg, IP). These findings collectively indicate that, in C57BL/6 mice, 5αR differentially modulates the effects of D(1)- and D(2)-like receptor agonists in behavioral regulation.
    MeSH term(s) 5-alpha Reductase Inhibitors/pharmacology ; Animals ; Apomorphine/pharmacology ; Benzazepines/antagonists & inhibitors ; Benzazepines/pharmacology ; Catalepsy/prevention & control ; Dopamine Agonists/pharmacology ; Dopamine Antagonists/pharmacology ; Dose-Response Relationship, Drug ; Drug Interactions ; Finasteride/pharmacology ; Haloperidol/pharmacology ; Male ; Mice ; Mice, Inbred C57BL ; Motor Activity/drug effects ; Quinpirole/pharmacology ; Sensory Gating/drug effects ; Stereotyped Behavior/drug effects
    Chemical Substances 5-alpha Reductase Inhibitors ; Benzazepines ; Dopamine Agonists ; Dopamine Antagonists ; Quinpirole (20OP60125T) ; Finasteride (57GNO57U7G) ; SK&F 82958 (80751-65-1) ; Haloperidol (J6292F8L3D) ; Apomorphine (N21FAR7B4S)
    Language English
    Publishing date 2012-08-09
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 197636-9
    ISSN 1873-3360 ; 0306-4530
    ISSN (online) 1873-3360
    ISSN 0306-4530
    DOI 10.1016/j.psyneuen.2012.07.014
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Chronic tryptophan deprivation attenuates gating deficits induced by 5-HT(1A), but not 5-HT₂ receptor activation.

    Stancampiano, Roberto / Frau, Roberto / Bini, Valentina / Collu, Maria / Carta, Manolo / Fadda, Fabio / Bortolato, Marco

    European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology

    2012  Volume 23, Issue 10, Page(s) 1329–1335

    Abstract: The neurotransmitter serotonin (5-hydroxytryptamine; 5-HT) exerts a multifaceted function in the modulation of information processing, through the activation of multiple receptor families. In particular, stimulation of 5-HT(1A) and 5-HT(2A) receptors ... ...

    Abstract The neurotransmitter serotonin (5-hydroxytryptamine; 5-HT) exerts a multifaceted function in the modulation of information processing, through the activation of multiple receptor families. In particular, stimulation of 5-HT(1A) and 5-HT(2A) receptors leads to sensorimotor gating impairments and perceptual perturbations. Previous evidence has shown that chronic deprivation of L-tryptophan (TRP), the precursor of 5-HT, results in marked reductions of 5-HT brain levels, as well as neuroplastic alterations in 5-HT(1A) and 5-HT(2A) expression and/or signaling. Building on these premises, in the present study we tested whether a prolonged TRP deprivation may differentially impact the roles of these receptors in the regulation of the prepulse inhibition (PPI) of the acoustic startle reflex, a dependable index of gating. Male Sprague-Dawley rats were fed for 14 days with either a regimen with negligible TRP content (TR-) or the same diet supplemented of TRP (TR+). At the end of this schedule, rats were treated with the prototypical 5-HT(1A) receptor agonist 8-OH-DPAT (62.5-250 μg/kg, subcutaneous, s.c.) or the 5-HT₂ receptor agonist DOI (0.25-1 mg/kg, s.c.). Notably, the PPI deficits induced by 8-OH-DPAT in TR- rats were significantly milder than those observed in their TR+ counterparts; these effects were fully prevented by the 5-HT(1A) antagonist WAY-100135 (10 mg/kg, intraperitoneal). Conversely, TRP deprivation did not affect the PPI-disrupting properties of DOI. These findings suggest that prolonged 5-HT depletion attenuates the influence of 5-HT(1A), but not 5-HT₂ receptors on sensorimotor gating, confirming the distinct mechanisms of these two targets in PPI regulation.
    MeSH term(s) Acoustic Stimulation ; Animals ; Behavior, Animal/drug effects ; Brain/drug effects ; Brain/metabolism ; Dyskinesia, Drug-Induced/diet therapy ; Gait Disorders, Neurologic/chemically induced ; Gait Disorders, Neurologic/diet therapy ; Male ; Nerve Tissue Proteins/agonists ; Nerve Tissue Proteins/antagonists & inhibitors ; Nerve Tissue Proteins/metabolism ; Neural Inhibition/drug effects ; Random Allocation ; Rats ; Rats, Sprague-Dawley ; Receptor, Serotonin, 5-HT1A/chemistry ; Receptor, Serotonin, 5-HT1A/metabolism ; Receptors, Serotonin, 5-HT2/chemistry ; Receptors, Serotonin, 5-HT2/metabolism ; Reflex, Startle/drug effects ; Sensory Gating/drug effects ; Serotonergic Neurons/drug effects ; Serotonergic Neurons/metabolism ; Serotonin 5-HT1 Receptor Agonists/toxicity ; Serotonin 5-HT1 Receptor Antagonists/pharmacology ; Serotonin 5-HT2 Receptor Agonists/toxicity ; Tryptophan/antagonists & inhibitors ; Tryptophan/deficiency
    Chemical Substances Nerve Tissue Proteins ; Receptors, Serotonin, 5-HT2 ; Serotonin 5-HT1 Receptor Agonists ; Serotonin 5-HT1 Receptor Antagonists ; Serotonin 5-HT2 Receptor Agonists ; Receptor, Serotonin, 5-HT1A (112692-38-3) ; Tryptophan (8DUH1N11BX)
    Language English
    Publishing date 2012-11-06
    Publishing country Netherlands
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 1082947-7
    ISSN 1873-7862 ; 0924-977X
    ISSN (online) 1873-7862
    ISSN 0924-977X
    DOI 10.1016/j.euroneuro.2012.10.009
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top